Objective: To assess the safety profile of acarbose treatment over a 1-year period at a dose range of 50 300mg three times daily in patients with type 1 or type 2 diabetes mellitus. Results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback